Heart failure (HF) is a syndromic condition with a high incidence in current medicine. When the symptoms of HF progress, and become refractory, cardiac transplant is the best therapeutic option. However, due to the shortage of donors and the long waiting lists, many of those patients are candidates for implantation of ventricular assist devices as a bridge to the cardiac transplant, or when this is not an option, as a definitive therapy. A series of four clinical cases of patients with ventricular assist devices that required surgical intervention, is presented. Three of them were assisted with long-term care: two EXCOR (pulsatile and para-corporeal) and one HEARTWARE (non-pulsatile and intra-corporeal), and the last one with short-term assistance; CentriMag biventricular Levitronix. There is no significant literature on the peri-operative implications of these patients when they undergo urgent or scheduled surgery. The experience in our centre leads us to raise the need to determine a series of aspects: operation of each device, emphasising the correct placement of the cannulas during the surgery; the proper management of any medication, emphasising the importance of anticoagulant and anti-platelet therapies; the Pathophysiological changes at cardiopulmonary level due to the implantation of these devices; and the importance of the administration of a correct antibiotic therapy. Given the complexity of these cases, the limited experience in this field, and the few cases that exist in these situations, it is recommended to create protocols to ensure their proper management.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.redar.2018.07.002DOI Listing

Publication Analysis

Top Keywords

ventricular assist
12
assist devices
12
patients ventricular
8
cardiac transplant
8
proper management
8
experience anaesthetic
4
anaesthetic management
4
management non-cardiac
4
non-cardiac surgery
4
patients
4

Similar Publications

Background: We describe our clinical experience performing device exchange from a HeartMate II (HM2) or HVAD to a HeartMate 3 (HM3) left ventricular assist device.

Methods: A single-center retrospective study was performed of all patients (N = 14) who underwent a left ventricular assist device exchange from HM2 (n = 7) or HVAD (n = 7) to HM3 between October 2018 and October 2021. The primary outcome was 1-year overall survival, and secondary outcomes included adverse events through discharge.

View Article and Find Full Text PDF

A patient with a history of Asian flu, mumps meningo-encephalitis, and skull-base fracture and severe porencephaly who was able to walk without assistance, has not been reported. The patient is a 65 year-old male with a history of Asian flu at 6 months of age, Mumps meningoencephalitis at 6 years of age, structural epilepsy since 15 years of age, traumatic brain injury with skull-base fracture at 51 years of age, arterial hypertension, diabetes, hyperlipidemia, previous alcoholism, and polyneuropathy. He presented with only mild right-sided spastic hemiparesis, dysarthria, decreased tendon reflexes in the lower limbs, spastic-ataxic gait, but he was able to walk unassisted.

View Article and Find Full Text PDF

A 67-year-old man with medical history of ischemic cardiomyopathy with stage D heart failure and infrarenal abdominal aortic aneurysm underwent implantation of a left ventricular assist device (LVAD). Three months after the procedure, he presented with unrelenting back pain and a rapidly increased in size aneurysm. The patient underwent urgent endovascular aneurysm repair with uncomplicated recovery.

View Article and Find Full Text PDF

This report describes the successful treatment of persistent ventricular tachycardia in a 66-year-old patient with ischemic cardiomyopathy during left ventricular assist device (LVAD) implantation. Recurrent episodes of ventricular tachycardia led to cardiac decompensation necessitating LVAD implantation. After opening the left ventricle, an AtriCure Isolator Synergy OLL2 radiofrequency clamp was used to perform 4 sets of transmural lesions.

View Article and Find Full Text PDF

Robot-Assisted Removal of a Recurrent Left Ventricular Myxoma.

Ann Thorac Surg Short Rep

March 2023

Department of Cardiac Surgery, Emory St Joseph's Hospital, Atlanta, Georgia.

Ventricular myxomas are rare compared with atrial myxomas. Unlike with atrial myxomas, it is usually challenging to visualize a ventricular mass because of the complex structures in the left ventricle. We report the case of a 44-year-old woman who had a recurrent left ventricular myxoma 8 years after the initial surgical removal.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!